Sprycel and Vasculitis - a phase IV clinical study of FDA data

Summary:

Vasculitis is reported as a side effect among people who take Sprycel (dasatinib), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Prednisolone, and have Acute lymphocytic leukaemia recurrent.

The phase IV clinical study analyzes which people have Vasculitis when taking Sprycel. It is created by eHealthMe based on reports of 29,638 people who have side effects when taking Sprycel from the FDA, and is updated regularly.

What is Sprycel?

Sprycel has active ingredients of dasatinib. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 29,788 Sprycel users. Check the latest studies of Sprycel.

What is Vasculitis?

Vasculitis (inflammation of a blood vessel or blood vessels) is found to be associated with 998 drugs and 1,207 conditions by eHealthMe. Check the latest studies of Vasculitis.

On Dec, 06, 2025

29,638 people reported to have side effects when taking Sprycel.
Among them, 12 people (0.04%) have Vasculitis.

Among these 12 people:

How long have people been on Sprycel when they have Vasculitis? *

What is the gender of people who have Vasculitis when taking Sprycel? *

female: 10 %
male: 90 %

What is the age of people who have Vasculitis when taking Sprycel? *

What are other drugs people take besides Sprycel? *

Prednisolone: 5 people, 41.67%
Oncovin: 4 people, 33.33%
Diflucan: 4 people, 33.33%
Cyclophosphamide: 3 people, 25.00%
Methotrexate: 2 people, 16.67%
Carvedilol: 2 people, 16.67%
Ultracet: 1 person, 8.33%
Sulfamethoxazole And Trimethoprim: 1 person, 8.33%
Omeprazole: 1 person, 8.33%
Levofloxacin: 1 person, 8.33%

What are other side effects people have besides Vasculitis? *

Rashes (redness): 6 people, 50.00%
White Blood Cell Count Decreased: 5 people, 41.67%
Thrombocytopenia (decrease of platelets in blood): 5 people, 41.67%
Pleural Effusion (water on the lungs): 5 people, 41.67%
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 5 people, 41.67%
Muscle Aches (muscle pain): 5 people, 41.67%
Anaemia (lack of blood): 5 people, 41.67%
Arrhythmias (irregular heartbeat): 4 people, 33.33%
Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot): 3 people, 25.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 25.00%

What are the existing conditions these people have? *

Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 7 people, 58.33%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 4 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Sprycel and have Vasculitis?

- Check whether Vasculitis is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sprycel:

Sprycel (29,788 reports)

Vasculitis treatments and more:

Vasculitis (18,555 reports)

Browse all side effects of Sprycel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vasculitis:

Vasculitis (998 drugs)

Browse all the conditions that are associated with Vasculitis:

Vasculitis (1,207 conditions)

Drugs similar to Sprycel and Vasculitis :

Gleevec side effect: Vasculitis

How the study uses the data?

The study uses data from the FDA. It is based on dasatinib (the active ingredients of Sprycel) and Sprycel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.